171 Oncology journals (Medicine) in ORBIT Tier 1 with at least 10 papers in 2025. ORBIT Tier 1: top quarter of Medicine by citation impact, our own ranking. Not a Scopus or Web of Science quartile.
As of 2 October 2026. From OpenAlex, Crossref and DOAJ. ORBIT Tier is our own ranking within a field, not a Scopus or Web of Science quartile.
| Journal | ISSN | Papers in 2025 | ORBIT Tier | Fee to publish | Open access | DOAJ | Country |
|---|---|---|---|---|---|---|---|
| Journal of Clinical Oncology | 0732-183X | 8,704 | 1 | Fee not published | No | No | United States |
| Annals of Oncology | 0923-7534 | 5,417 | 1 | Free via subscription (paywalled) | No | No | Netherlands |
| Frontiers in Oncology | 2234-943X | 4,580 | 1 | ≈ ₹3,63,273 to publish | Yes | Yes | Switzerland |
| Cancers | 2072-6694 | 4,092 | 1 | ≈ ₹3,37,054 to publish | Yes | No | Switzerland |
| Journal of Molecular Structure | 0022-2860 | 3,575 | 1 | Free via subscription (paywalled) | No | No | Netherlands |
| Clinical Cancer Research | 1078-0432 | 2,761 | 1 | Fee not published | No | No | United States |
| BMC Cancer | 1471-2407 | 2,104 | 1 | ≈ ₹3,42,821 to publish | Yes | Yes | United Kingdom |
| ESMO Open | 2059-7029 | 1,641 | 1 | ≈ ₹4,15,176 to publish | Yes | Yes | Netherlands |
| Journal of Translational Medicine | 1479-5876 | 1,581 | 1 | ≈ ₹3,64,587 to publish | Yes | Yes | United Kingdom |
| Journal of Inflammation Research | 1178-7031 | 1,172 | 1 | ≈ ₹4,16,139 to publish | Yes | Yes | New Zealand |
| Supportive Care in Cancer | 0941-4355 | 1,163 | 1 | Free via subscription (paywalled) | No | No | Germany |
| Cancer Medicine | 2045-7634 | 1,016 | 1 | ≈ ₹4,78,753 to publish | Yes | Yes | United Kingdom |
| Current Oncology | 1198-0052 | 711 | 1 | ≈ ₹2,53,715 to publish | Yes | Yes | Canada |
| Journal for ImmunoTherapy of Cancer | 2051-1426 | 704 | 1 | ≈ ₹3,04,673 to publish | Yes | Yes | United Kingdom |
| The Oncologist | 1083-7159 | 575 | 1 | ≈ ₹3,53,333 to publish | Yes | Yes | United Kingdom |
| Cancer | 0008-543X | 567 | 1 | Free via subscription (paywalled) | No | No | United States |
| Applied Organometallic Chemistry | 0268-2605 | 556 | 1 | Free via subscription (paywalled) | No | No | United Kingdom |
| Anticancer Research | 0250-7005 | 539 | 1 | Fee not published | No | No | Greece |
| MedComm | 2688-2663 | 533 | 1 | ≈ ₹3,70,865 to publish | Yes | Yes | China |
| Asian Pacific Journal of Cancer Prevention | 1513-7368 | 532 | 1 | ≈ ₹38,531 to publish | Yes | Yes | Iran |
| The Lancet Oncology | 1470-2045 | 503 | 1 | Free via subscription (paywalled) | No | No | United Kingdom |
| Polyhedron | 0277-5387 | 485 | 1 | Free via subscription (paywalled) | No | No | United Kingdom |
| Inorganica Chimica Acta | 0020-1693 | 463 | 1 | Free via subscription (paywalled) | No | No | Netherlands |
| Cell Reports Medicine | 2666-3791 | 455 | 1 | ≈ ₹5,57,742 to publish | Yes | Yes | United States |
| Cancer Immunology Research | 2326-6066 | 451 | 1 | Fee not published | No | No | United States |
| World Journal of Gastrointestinal Oncology | 1948-5204 | 426 | 1 | Fee not published | Yes | No | United States |
| Inorganics | 2304-6740 | 424 | 1 | ≈ ₹3,11,377 to publish | Yes | Yes | Switzerland |
| Critical Reviews in Oncology/Hematology | 1040-8428 | 417 | 1 | Free via subscription (paywalled) | No | No | Netherlands |
| Clinical and Translational Medicine | 2001-1326 | 416 | 1 | ≈ ₹3,50,636 to publish | Yes | Yes | United States |
| Oncogene | 0950-9232 | 403 | 1 | Free via subscription (paywalled) | No | No | United Kingdom |
| Cancer Discovery | 2159-8274 | 400 | 1 | Fee not published | No | No | United States |
| Translational Oncology | 1936-5233 | 378 | 1 | ≈ ₹3,73,755 to publish | Yes | Yes | United States |
| British Journal of Cancer | 0007-0920 | 374 | 1 | Free via subscription (paywalled) | No | No | United Kingdom |
| Cancer Reports | 2573-8348 | 354 | 1 | ≈ ₹3,31,370 to publish | Yes | Yes | United States |
| Future Oncology | 1479-6694 | 351 | 1 | Fee not published | No | No | United Kingdom |
| Psycho-Oncology | 1057-9249 | 340 | 1 | Free via subscription (paywalled) | No | No | United Kingdom |
| JAMA Oncology | 2374-2437 | 337 | 1 | Fee not published | No | No | United States |
| Journal of Inorganic Biochemistry | 0162-0134 | 329 | 1 | Free via subscription (paywalled) | No | No | United States |
| Journal of Cancer Research and Clinical Oncology | 0084-5353 | 327 | 1 | ≈ ₹3,58,057 to publish | Yes | Yes | Germany |
| Clinical & Translational Oncology | 1699-048X | 325 | 1 | Free via subscription (paywalled) | No | No | Spain |
| In Vivo | 0258-851X | 305 | 1 | Fee not published | Yes | No | Greece |
| Therapeutic Advances in Medical Oncology | 1758-8340 | 279 | 1 | ≈ ₹2,69,720 to publish | Yes | Yes | United Kingdom |
| European Journal of Oncology Nursing | 1462-3889 | 274 | 1 | Free via subscription (paywalled) | No | No | United Kingdom |
| JCO Global Oncology | 2687-8941 | 274 | 1 | ≈ ₹2,38,124 to publish | Yes | Yes | United States |
| Biological and Pharmaceutical Bulletin | 0918-6158 | 250 | 1 | ≈ ₹54,876 to publish | Yes | Yes | Japan |
| Journal of Cancer Education | 0885-8195 | 250 | 1 | Free via subscription (paywalled) | No | No | United States |
| World Journal of Clinical Oncology | 2218-4333 | 250 | 1 | Fee not published | Yes | No | United States |
| Cancer Control | 1073-2748 | 245 | 1 | ≈ ₹2,55,271 to publish | Yes | Yes | United States |
| Journal of Gastrointestinal Oncology | 2078-6891 | 239 | 1 | Fee not published | Yes | No | Hong Kong SAR China |
| Modern Pathology | 0893-3952 | 236 | 1 | Free via subscription (paywalled) | No | No | United States |
| ecancermedicalscience | 1754-6605 | 229 | 1 | ≈ ₹1,27,478 to publish | Yes | Yes | United Kingdom |
| Cellular and Molecular Gastroenterology and Hepatology | 2352-345X | 220 | 1 | ≈ ₹3,63,159 to publish | Yes | Yes | Netherlands |
| Journal of Cancer Survivorship | 1932-2259 | 219 | 1 | Free via subscription (paywalled) | No | No | United States |
| Cancer Cell | 1535-6108 | 216 | 1 | Free via subscription (paywalled) | No | No | Netherlands |
| Biomolecules and Biomedicine | 2831-0896 | 214 | 1 | ≈ ₹1,30,054 to publish | Yes | Yes | Bosnia & Herzegovina |
| Journal of Gastrointestinal Cancer | 1941-6628 | 212 | 1 | Free via subscription (paywalled) | No | No | United States |
| Cell Proliferation | 0960-7722 | 209 | 1 | ≈ ₹3,37,379 to publish | Yes | Yes | United Kingdom |
| Nature Cancer | 2662-1347 | 204 | 1 | Free via subscription (paywalled) | No | No | United States |
| Cancer Epidemiology | 1877-7821 | 202 | 1 | Free via subscription (paywalled) | No | No | Netherlands |
| Cancer Research Communications | 2767-9764 | 194 | 1 | ≈ ₹2,45,638 to publish | Yes | Yes | United States |
| Asia-Pacific Journal of Oncology Nursing | 2347-5625 | 193 | 1 | ≈ ₹2,38,895 to publish | Yes | Yes | India |
| Expert Review of Anticancer Therapy | 1473-7140 | 187 | 1 | Fee not published | No | No | United Kingdom |
| JCO Clinical Cancer Informatics | 2473-4276 | 179 | 1 | Fee not published | No | No | United States |
| Molecular Therapy Oncology | 2950-3299 | 167 | 1 | ≈ ₹3,75,681 to publish | Yes | Yes | |
| Biomarker Research | 2050-7771 | 166 | 1 | ≈ ₹3,47,174 to publish | Yes | Yes | United Kingdom |
| Med | 2666-6340 | 166 | 1 | Free via subscription (paywalled) | No | No | United States |
| Cancer Research and Treatment | 1598-2998 | 164 | 1 | Fee not published | Yes | No | South Korea |
| Molecular Carcinogenesis | 0899-1987 | 164 | 1 | Free via subscription (paywalled) | No | No | United States |
| Journal of Coordination Chemistry | 0095-8972 | 160 | 1 | Fee not published | No | No | Netherlands |
| Journal of Patient-Reported Outcomes | 2509-8020 | 157 | 1 | ≈ ₹1,94,809 to publish | Yes | Yes | United Kingdom |
| The Journal of Pathology | 0022-3417 | 156 | 1 | Free via subscription (paywalled) | No | No | |
| Seminars in Oncology Nursing | 0749-2081 | 154 | 1 | Free via subscription (paywalled) | No | No | United States |
| JMIR Cancer | 2369-1999 | 151 | 1 | ≈ ₹1,91,212 to publish | Yes | Yes | Canada |
| Cancer Causes & Control | 0957-5243 | 148 | 1 | Free via subscription (paywalled) | No | No | Netherlands |
| Biomarkers in Medicine | 1752-0363 | 143 | 1 | Fee not published | No | No | United Kingdom |
| ESMO Gastrointestinal Oncology | 2949-8198 | 141 | 1 | ≈ ₹3,35,223 to publish | Yes | Yes | |
| Experimental Hematology and Oncology | 2162-3619 | 141 | 1 | ≈ ₹3,25,408 to publish | Yes | Yes | United Kingdom |
| Journal of Cancer Policy | 2213-5383 | 140 | 1 | Free via subscription (paywalled) | No | No | Netherlands |
| Cancer Treatment Reviews | 0305-7372 | 136 | 1 | Free via subscription (paywalled) | No | No | United Kingdom |
| Immunotherapy | 1750-743X | 135 | 1 | Fee not published | No | No | United Kingdom |
| International Journal of Oncology | 1019-6439 | 127 | 1 | Fee not published | No | No | Greece |
| Surgical Oncology | 0960-7404 | 127 | 1 | Free via subscription (paywalled) | No | No | United Kingdom |
| Current Cancer Drug Targets | 1568-0096 | 125 | 1 | Fee not published | No | No | Netherlands |
| Integrative Cancer Therapies | 1534-7354 | 124 | 1 | ≈ ₹2,55,271 to publish | Yes | Yes | United States |
| JNCI Cancer Spectrum | 2515-5091 | 123 | 1 | ≈ ₹1,87,937 to publish | Yes | Yes | United Kingdom |
| Journal of Chemical Sciences | 0253-4134 | 123 | 1 | Fee not published | No | No | India |
| Seminars in Cancer Biology | 1044-579X | 123 | 1 | Free via subscription (paywalled) | No | No | United States |
| Cancer Biology and Medicine | 2095-3941 | 120 | 1 | ≈ ₹2,69,720 to publish | Yes | Yes | China |
| OncoImmunology | 2162-4011 | 120 | 1 | ≈ ₹3,17,884 to publish | Yes | Yes | United States |
| Current Oncology Reports | 1523-3790 | 115 | 1 | Free via subscription (paywalled) | No | No | United States |
| Oncology | 0030-2414 | 113 | 1 | Fee not published | No | No | Switzerland |
| Cancer Chemotherapy and Pharmacology | 0344-5704 | 112 | 1 | Free via subscription (paywalled) | No | No | Germany |
| Cellular Oncology | 1570-5870 | 105 | 1 | ≈ ₹2,29,262 to publish | Yes | Yes | Netherlands |
| Molecular and Clinical Oncology | 2049-9450 | 105 | 1 | Fee not published | Yes | No | United Kingdom |
| Cancer Nursing | 0162-220X | 102 | 1 | Fee not published | No | No | United States |
| Investigational New Drugs | 0167-6997 | 101 | 1 | Free via subscription (paywalled) | No | No | Netherlands |
| Seminars in Oncology | 0093-7754 | 96 | 1 | Free via subscription (paywalled) | No | No | United States |
| Cancer Investigation | 0735-7907 | 92 | 1 | Fee not published | No | No | United Kingdom |
| Current Opinion in Oncology | 1040-8746 | 89 | 1 | Fee not published | No | No | United Kingdom |
| ImmunoTargets and Therapy | 2253-1556 | 89 | 1 | ≈ ₹4,16,139 to publish | Yes | Yes | New Zealand |
The first 100 of 171 journals, by papers published in 2025. The rest load in the browser, with search, sort and filters.